KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Astrana Health (ASTH) Receivables - Other (2016 - 2025)

Astrana Health's Receivables - Other history spans 15 years, with the latest figure at $9.9 million for Q3 2025.

  • For Q3 2025, Receivables - Other rose 783.13% year-over-year to $9.9 million; the TTM value through Sep 2025 reached $9.9 million, up 783.13%, while the annual FY2024 figure was $29.5 million, 2109.44% up from the prior year.
  • Receivables - Other for Q3 2025 was $9.9 million at Astrana Health, up from $8.7 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $91.2 million in Q3 2022 and bottomed at $1.1 million in Q3 2024.
  • The 5-year median for Receivables - Other is $13.3 million (2022), against an average of $31.2 million.
  • The largest annual shift saw Receivables - Other crashed 98.53% in 2023 before it soared 2109.44% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $69.4 million in 2021, then plummeted by 97.36% to $1.8 million in 2022, then fell by 27.21% to $1.3 million in 2023, then skyrocketed by 2109.44% to $29.5 million in 2024, then crashed by 66.47% to $9.9 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Receivables - Other are $9.9 million (Q3 2025), $8.7 million (Q2 2025), and $14.9 million (Q1 2025).